Actively Recruiting
Real-World Study of Paxlovid Treatment in Hospitalized Patients with COVID-19
Led by Huashan Hospital · Updated on 2022-05-24
2000
Participants Needed
1
Research Sites
208 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying how well and how safely Paxlovid works for treating patients hospitalized with COVID-19. This real-world study collects medical records from patients visiting Huashan Hospital affiliated to Fudan University between 2022 and 2027. The research aims to understand the effects of Paxlovid and factors that may influence the outcomes for COVID-19 patients. The study compares two groups patients receiving Paxlovid therapy and those receiving routine therapy without Paxlovid. The exact use of Paxlovid is based on patients medical history as recorded in their treatment. Data on demographics, clinical features, lab tests, treatment history, adverse reactions, and treatment results will be gathered and analyzed. Participants will have their viral shedding time and disease progression tracked for up to 28 days. Researchers will also monitor adverse events and recovery times. Data on how many patients test negative for the virus and their clinical recovery will be measured. The study collects information from medical records without altering patients usual care, and results will help understand Paxlovids role in COVID-19 treatment.
CONDITIONS
Brief Title
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
Research Team
F
Feng Sun, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
